Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04584255
Title Niraparib + TSR042 In BRCA Mutated Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

Her2-receptor negative breast cancer

Therapies

Dostarlimab-gxly + Niraparib

Niraparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Mayo Clinic Recruiting Rochester Minnesota 55905 United States Details
Vanderbilt-Ingram Cancer Center Not yet recruiting Nashville Tennessee 37232 United States Details
Baylor College of Medicine Medical Center Not yet recruiting Houston Texas 77030 United States Details
Harris Health System - Smith Clinic Not yet recruiting Houston Texas 77054 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field